Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Gleevec Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 100mg
  • 1.3.3 400mg
• 1.4 Market Segment by Application
  • 1.4.1 Global Gleevec Market Share by Application (2019-2025)
  • 1.4.2 Hospital
  • 1.4.3 Pharmacy
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Gleevec Market Size
  • 2.1.1 Global Gleevec Revenue 2014-2025
  • 2.1.2 Global Gleevec Sales 2014-2025
• 2.2 Gleevec Growth Rate by Regions
  • 2.2.1 Global Gleevec Sales by Regions 2014-2019
  • 2.2.2 Global Gleevec Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Gleevec Sales by Manufacturers
  • 3.1.1 Gleevec Sales by Manufacturers 2014-2019
  • 3.1.2 Gleevec Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Gleevec Revenue by Manufacturers (2014-2019)
  • 3.2.2 Gleevec Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Gleevec Market Concentration Ratio (CR5 and HHI)
• 3.3 Gleevec Price by Manufacturers
• 3.4 Key Manufacturers Gleevec Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Gleevec Market
• 3.6 Key Manufacturers Gleevec Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 100mg Sales and Revenue (2014-2019)
  • 4.1.2 400mg Sales and Revenue (2014-2019)
• 4.2 Global Gleevec Sales Market Share by Type
• 4.3 Global Gleevec Revenue Market Share by Type
• 4.4 Gleevec Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Gleevec Sales by Application

6 United States

• 6.1 United States Gleevec Breakdown Data by Company
• 6.2 United States Gleevec Breakdown Data by Type
• 6.3 United States Gleevec Breakdown Data by Application

7 European Union

• 7.1 European Union Gleevec Breakdown Data by Company
• 7.2 European Union Gleevec Breakdown Data by Type
• 7.3 European Union Gleevec Breakdown Data by Application

8 China

• 8.1 China Gleevec Breakdown Data by Company
• 8.2 China Gleevec Breakdown Data by Type
• 8.3 China Gleevec Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Gleevec Breakdown Data by Company
• 9.2 Rest of World Gleevec Breakdown Data by Type
• 9.3 Rest of World Gleevec Breakdown Data by Application
• 9.4 Rest of World Gleevec Breakdown Data by Countries
  • 9.4.1 Rest of World Gleevec Sales by Countries
  • 9.4.2 Rest of World Gleevec Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Novartis
  • 10.1.1 Novartis Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Gleevec
  • 10.1.4 Gleevec Product Introduction
  • 10.1.5 Novartis Recent Development

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Gleevec Sales Channels
  • 11.2.2 Gleevec Distributors
• 11.3 Gleevec Customers

12 Market Forecast

• 12.1 Global Gleevec Sales and Revenue Forecast 2019-2025
• 12.2 Global Gleevec Sales Forecast by Type
• 12.3 Global Gleevec Sales Forecast by Application
• 12.4 Gleevec Forecast by Regions
  • 12.4.1 Global Gleevec Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Gleevec Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

Imatinib is a medication used to treat cancer.
In 2019, the market size of Gleevec is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Gleevec.

This report studies the global market size of Gleevec, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Gleevec sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Novartis
...

Market Segment by Product Type
100mg
400mg

Market Segment by Application
Hospital
Pharmacy

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Gleevec status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Gleevec manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Gleevec are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025